- Home
- ESPR vs LINC Comparison
ESPR vs LINC Comparison
Compare ESPR & LINC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- LINC
- Stock Information
- Founded
- ESPR 2008
- LINC 1946
- Country
- ESPR United States
- LINC United States
- Employees
- ESPR N/A
- LINC N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- LINC Other Consumer Services
- Sector
- ESPR Health Care
- LINC Real Estate
- Exchange
- ESPR Nasdaq
- LINC Nasdaq
- Market Cap
- ESPR 660.1M
- LINC 732.0M
- IPO Year
- ESPR 2013
- LINC 2005
- Fundamental
- Price
- ESPR $3.68
- LINC $20.44
- Analyst Decision
- ESPR Buy
- LINC Strong Buy
- Analyst Count
- ESPR 7
- LINC 3
- Target Price
- ESPR $6.86
- LINC $26.00
- AVG Volume (30 Days)
- ESPR 7.0M
- LINC 331.8K
- Earning Date
- ESPR 11-06-2025
- LINC 11-10-2025
- Dividend Yield
- ESPR N/A
- LINC N/A
- EPS Growth
- ESPR N/A
- LINC 40.12
- EPS
- ESPR N/A
- LINC 0.45
- Revenue
- ESPR $303,802,000.00
- LINC $494,742,000.00
- Revenue This Year
- ESPR $18.83
- LINC $14.51
- Revenue Next Year
- ESPR N/A
- LINC $8.40
- P/E Ratio
- ESPR N/A
- LINC $45.74
- Revenue Growth
- ESPR 2.83
- LINC 16.90
- 52 Week Low
- ESPR $0.69
- LINC $14.10
- 52 Week High
- ESPR $3.94
- LINC $25.76
- Technical
- Relative Strength Index (RSI)
- ESPR 71.27
- LINC 49.55
- Support Level
- ESPR $2.66
- LINC $19.39
- Resistance Level
- ESPR $3.26
- LINC $22.04
- Average True Range (ATR)
- ESPR 0.23
- LINC 1.14
- MACD
- ESPR 0.05
- LINC 0.09
- Stochastic Oscillator
- ESPR 94.43
- LINC 67.58
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About LINC Lincoln Educational Services Corporation
Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services, and business and information technology. Its reportable segments include; Campus Operations, and Transitional. The majority of the revenue is generated from the Campus Operations segment which includes all campuses that are continuing in operation and contribute to the Company's core operations and performance.